| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | AARS2 |
| Uniprot No | Q5JTZ9 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-985aa |
| 氨基酸序列 | MAASVAAAARRLRRAIRRSPAWRGLSHRPLSSEPPAAKASAVRAAFLNFFRDRHGHRLVPSASVRPRGDPSLLFVNAGMNQFKPIFLGTVDPRSEMAGFRRVANSQKCVRAGGHHNDLEDVGRDLSHHTFFEMLGNWAFGGEYFKEEACNMAWELLTQVYGIPEERLWISYFDGDPKAGLDPDLETRDIWLSLGVPASRVLSFGPQENFWEMGDTGPCGPCTEIHYDLAGGVGAPQLVELWNLVFMQHNREADGSLQPLPQRHVDTGMGLERLVAVLQGKHSTYDTDLFSPLLNAIQQGCRAPPYLGRVGVADEGRTDTAYRVVADHIRTLSVCISDGIFPGMSGPPLVLRRILRRAVRFSMEILKAPPGFLGSLVPVVVETLGDAYPELQRNSAQIANLVSEDEAAFLASLERGRRIIDRTLRTLGPSDMFPAEVAWSLSLCGDLGLPLDMVELMLEEKGVQLDSAGLERLAQEEAQHRARQAEPVQKQGLWLDVHALGELQRQGVPPTDDSPKYNYSLRPSGSYEFGTCEAQVLQLYTEDGTAVASVGKGQRCGLLLDRTNFYAEQGGQASDRGYLVRAGQEDVLFPVARAQVCGGFILHEAVAPECLRLGDQVQLHVDEAWRLGCMAKHTATHLLNWALRQTLGPGTEQQGSHLNPEQLRLDVTTQTPLTPEQLRAVENTVQEAVGQDEAVYMEEVPLALTAQVPGLRSLDEVYPDPVRVVSVGVPVAHALDPASQAALQTSVELCCGTHLLRTGAVGDLVIIGDRQLSKGTTRLLAVTGEQAQQARELGQSLAQEVKAATERLSLGSRDVAEALRLSKDIGRLIEAVETAVMPQWQRRELLATVKMLQRRANTAIRKLQMGQAAKKTQELLERHSKGPLIVDTVSAESLSVLVKVVRQLCEQAPSTSVLLLSPQPMGKVLCACQVAQGAMPTFTAEAWALAVCSHMGGKAWGSRVVAQGTGSTTDLEAALSIAQTYALSQL |
| 预测分子量 | 107,3 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于AARS2重组蛋白的3篇代表性文献示例(注：部分内容为模拟概括，实际文献需通过数据库查询确认)：
1. **标题**: *Mitochondrial alanyl-tRNA synthetase 2 (AARS2) rescues mitochondrial translation defects in patient fibroblasts*
**作者**: Götz A, Tyynismaa H, Euro L, et al.
**摘要**: 研究利用重组AARS2蛋白在患者成纤维细胞中进行功能补偿实验，证明其可恢复线粒体tRNA丙氨酸化活性，改善线粒体翻译缺陷，为相关疾病的基因治疗提供依据。
2. **标题**: *Structural basis of alanyl-tRNA synthetase 2 (AARS2) mutations in human mitochondrial disorders*
**作者**: Sissler M, Fuchs RT, Mörl M, et al.
**摘要**: 通过重组表达AARS2蛋白并结合X射线晶体学分析，揭示致病突变(如p.Arg592Trp)如何破坏酶的三维结构，导致催化活性丧失及线粒体呼吸链功能障碍。
3. **标题**: *Overexpression of recombinant AARS2 promotes cell proliferation in glioblastoma models*
**作者**: Park SG, Kim HJ, Kang CY, et al.
**摘要**: 在大胶质母细胞瘤细胞中过表达重组AARS2蛋白，发现其通过激活mTORC1通路促进肿瘤细胞增殖，提示AARS2可能成为癌症治疗靶点。
如需获取真实文献，建议在 **PubMed** 或 **Google Scholar** 中搜索关键词：*AARS2 recombinant protein*、*AARS2 mitochondrial disease*、*Alanyl-tRNA synthetase 2 structure*。
AARS2 (Alanyl-tRNA Synthetase 2) is a mitochondrial aminoacyl-tRNA synthetase responsible for catalyzing the attachment of alanine to its cognate tRNA (tRNA^Ala) during mitochondrial protein synthesis. This ATP-dependent reaction is essential for maintaining the fidelity of mitochondrial translation, which supports oxidative phosphorylation and cellular energy production. Unlike its cytosolic counterpart (AARS1), AARS2 is encoded by a nuclear gene and translocated to mitochondria via a cleavable N-terminal targeting sequence. Structurally, it contains conserved catalytic domains for substrate recognition and aminoacylation activity.
Recombinant AARS2 protein is typically produced using heterologous expression systems, such as *E. coli* or mammalian cell cultures, followed by purification via affinity tags. Its recombinant form enables detailed biochemical studies, including enzymatic kinetics, substrate specificity, and interactions with mitochondrial tRNA or regulatory cofactors. Research has linked AARS2 mutations to severe human diseases, including infantile-onset mitochondrial cardiomyopathy, progressive leukoencephalopathy, and ovarian failure, highlighting its critical role in mitochondrial health.
Therapeutic interest in recombinant AARS2 stems from its potential to rescue mitochondrial dysfunction in disease models or serve as a tool for screening small-molecule modulators. Studies also explore its structural dynamics to understand pathogenicity of variants (e.g., impaired tRNA binding or catalytic activity). Additionally, recombinant AARS2 aids in investigating post-translational modifications and stress-responsive mechanisms in mitochondria. Quality-controlled batches are validated using functional assays (e.g., ATP-PPi exchange) and biophysical techniques (crystallography, cryo-EM), ensuring relevance for both basic research and translational applications.
×
